319 related articles for article (PubMed ID: 35563591)
1. Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model.
Arora A; Tripodi GL; Kareinen I; Berg M; Forteza MJ; Gisterå A; Griepke S; Casagrande FB; Martins JO; Abdalla DSP; Cole J; Monaco C; Ketelhuth DFJ
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563591
[TBL] [Abstract][Full Text] [Related]
2. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
Ouyang L; Yu C; Xie Z; Su X; Xu Z; Song P; Li J; Huang H; Ding Y; Zou MH
Circulation; 2022 Jun; 145(24):1784-1798. PubMed ID: 35582948
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF
Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis.
Wu C; Li J; Jia H; Zhao J; Qin M; Shi H; Liu C; Lin J; Cai M; Gu Y; Liu B; Gao L
J Gastroenterol; 2024 Apr; 59(4):342-356. PubMed ID: 38402297
[TBL] [Abstract][Full Text] [Related]
6. Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism.
Trézéguet V; Fatrouni H; Merched AJ
Cells; 2021 Dec; 10(12):. PubMed ID: 34943977
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan degradation enzymes expression in the placenta and the Kynurenine/Tryptophan ratio in maternal plasma after elective cesarean section.
Silvano A; Seravalli V; Strambi N; Vallario A; Tofani L; Parenti A; Di Tommaso M
J Reprod Immunol; 2023 Mar; 156():103823. PubMed ID: 36739732
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications.
Liu G; Chen S; Zhong J; Teng K; Yin Y
Oxid Med Cell Longev; 2017; 2017():1602074. PubMed ID: 28377795
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival.
Souissi S; Ghedira R; Macherki Y; Ben-Haj-Ayed A; Gabbouj S; Remadi Y; Sfar I; Chadli Z; Aouam K; Hassine M; Bouaouina N; Zakhama A; Hassen E
Immun Inflamm Dis; 2022 Sep; 10(9):e690. PubMed ID: 36039641
[TBL] [Abstract][Full Text] [Related]
11. Quantification of IDO1 enzyme activity in normal and malignant tissues.
Zhai L; Ladomersky E; Bell A; Dussold C; Cardoza K; Qian J; Lauing KL; Wainwright DA
Methods Enzymol; 2019; 629():235-256. PubMed ID: 31727243
[TBL] [Abstract][Full Text] [Related]
12. Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.
Ohta Y; Kubo H; Yashiro K; Ohashi K; Tsuzuki Y; Wada N; Yamamoto Y; Saito K
J Physiol Sci; 2017 May; 67(3):361-372. PubMed ID: 27364617
[TBL] [Abstract][Full Text] [Related]
13. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
[TBL] [Abstract][Full Text] [Related]
15. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
Baumgartner R; Forteza MJ; Ketelhuth DFJ
Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C
Front Immunol; 2021; 12():713989. PubMed ID: 34394118
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
18. Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression.
Crump LS; Floyd JL; Kuo LW; Post MD; Bickerdike M; O'Neill K; Sompel K; Jordan KR; Corr BR; Marjon N; Woodruff ER; Richer JK; Bitler BG
Cancer Res Commun; 2024 Mar; 4(3):822-833. PubMed ID: 38451784
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice.
Forteza MJ; Polyzos KA; Baumgartner R; Suur BE; Mussbacher M; Johansson DK; Hermansson A; Hansson GK; Ketelhuth DFJ
Front Immunol; 2018; 9():950. PubMed ID: 29867939
[TBL] [Abstract][Full Text] [Related]
20. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
